EBV VCA IgG ELISA Kit

Catalog No. ABIN1326837

This Human EBV VCA IgG ELISA Kit is a Colorimetric ELISA Kit designed to quantify Human EBV VCA IgG. This ELISA Kit has been cited in1 publication.

Quick Overview for EBV VCA IgG ELISA Kit (ABIN1326837)

Target: EBV VCA IgG (Anti-Epstein-Barr Virus Viral Capsid Antigen IgG (EBV VCA IgG))

Reactivity: Human

Detection Method: Colorimetric

Method Type: Competition ELISA

Application: ELISA

Sample Type: Serum

Product Details EBV VCA IgG ELISA Kit

Purpose: Diluted patient serum is added to wells coated with purified antigen. IgG specific antibody, if present, binds to the antigen. All unbound materials are washed away and the enzyme conjugate is added to bind to the antibody-antigen complex, if present. Excess enzyme conjugate is washed off and substrate is added. The plate is incubated to allow the hydrolysis of the substrate by the enzyme. The intensity of the color generated is proportional to the amount of IgG specific antibody in the sample

Analytical Method: Qualitative

Application Details

Plate: Pre-coated

Restrictions: For Research Use only

Handling

Storage: 4 °C

References for EBV VCA IgG ELISA Kit (ABIN1326837)

Wang, Liu, Xu, Jackson, Roskin, Pham, Laserson, Marshall, Seo, Lee, Furman, Koller, Dekker, Davis, Fire, Boyd: "Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 2, pp. 603-11, (2014) (PubMed).

Target Details for EBV VCA IgG

Target: EBV VCA IgG (Anti-Epstein-Barr Virus Viral Capsid Antigen IgG (EBV VCA IgG))

Alternative Name: EBV-VCA IgG

Target Type: Antibody, Antibody

Background: Epstein-Barr virus (EBV) is a herpes virus known to cause infectious mononucleosis (IM). EBV infection may demonstrate a wide spectrum of clinical symptoms. The majorities of primary EBV infections are transmitted via saliva, occur during childhood, and are sub-clinical. In the U.S., 50% of the population demonstrate EBV antibodies before the age of 5 years 80% by adulthood. Transfusion-associated EBV infections have also been reported. Epstein-Barr virus has also been associated in the pathogenisis of two human cancers, Burkitt's lymphoma and nasopharyngeal carcinoma. Burkitt's lymphoma is primarily observed in Sub-Sahara Africa, especially in African children, and in New Guinea. Nasopharyngeal carcinoma is observed in Asia, most notably in Southern China.